MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41467-026-73819-1

Медицинская библиотека · Nature communications · 2026

Therapeutic effect of T-cell engager in two patients with autoimmune neuropathy.

Wickel Jonathan, Ceanga Mihai, Vlad Benjamin, von Stackelberg Nikolai, Tochoedo Nounagnon Romaric, Schulz Danilo, Yomade Olaposi, Dudziak Diana, Geis Christian

СтатьяКлинический случайПеревод в очереди

Аннотация

Chronic immune-mediated peripheral nerve myelinopathies (CIPNM) are progressive and debilitating disorders that can be refractory to current treatment regimes. The bispecific T-cell engager (BiTE) teclistamab depletes B-cell Maturation Antigen (BCMA) positive late-stage B- cells and plasma cells by engaging T-cells. We present two patients with treatment-refractory CIPNM (Patient 1: IgM-kappa-associated CIPNM, follow-up 9 months; Patient 2: Anti-myelin-associated-glycoprotein (MAG) antibody-mediated CIPNM, follow-up 6 months). Both patients are characterized by rapid improvement upon treatment with teclistamab: substantially increased walking distance, accompanied by reduced nerve swelling and markedly improved electroneurography. Furthermore, some nerves without stimulus response at baseline are showing detectable response during follow-up. The functional recovery of peripheral nerves is paralleled by decreased serum neurofilament levels, indicating reduced neuronal damage. IgM kappa paraprotein and high-titer MAG antibodies are undetectable 6 weeks after the first dose of teclistamab and remain negative throughout the follow-up, whereas soluble BCMA re-emerges following an initial reduction. No serious adverse events are observed during treatment. This case series highlights the significant therapeutic potential of teclistamab in treatment-refractory CIPNM and provides an important example of 'off-the-shelf' BiTE therapy being well tolerated and effective and should be further investigated in neuro-immunological disorders.

Для цитирования: Wickel Jonathan, Ceanga Mihai, Vlad Benjamin, von Stackelberg Nikolai, Tochoedo Nounagnon Romaric, Schulz Danilo, Yomade Olaposi, Dudziak Diana, Geis Christian. Therapeutic effect of T-cell engager in two patients with autoimmune neuropathy.. Nature communications. 2026. DOI: 10.1038/s41467-026-73819-1.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.